The globus pallidus externus (GPe) is a central nucleus in the basal ganglia's indirect pathway, composed primarily of GABAergic neurons that serve as a crucial relay station in motor control circuits. These neurons play essential roles in regulating movement, action selection, and motor learning. The GPe receives inhibitory input from striatal D2-expressing medium spiny neurons (D2-MSNs) and provides inhibitory outputs to the subthalamic nucleus (STN), globus pallidus internus (GPi), substantia nigra pars reticulata (SNr), and back to the striatum.
The globus pallidus externus (GPe) is a key node in the indirect pathway of the basal ganglia. It contains predominantly GABAergic projection neurons that modulate motor output through disinhibition and feedforward inhibition mechanisms. The GPe is characterized by heterogeneous neuronal populations with distinct molecular markers, firing properties, and projection patterns.
- Neurotransmitter: GABA (gamma-aminobutyric acid)
- Input: Striatal D2-MSNs, STN, cerebral cortex (via indirect routes)
- Output: STN, GPi, SNr, striatum
- Function: Motor suppression, action timing, movement sequencing
The GPe occupies a unique position in basal ganglia circuitry:
- Primary Input: Inhibitory connections from striatal D2-MSNs (indirect pathway)
- Major Outputs:
- excitatory projections to the STN
- inhibitory projections to GPi and SNr
- feedback connections to striatum
- Modulatory Input: Cortical inputs via the STN
- Cortex → Striatum (D2-MSNs)
- D2-MSNs → GPe (inhibition)
- GPe → STN (disinhibition/facilitates excitation)
- STN → GPi/SNr (excitation)
- GPi/SNr → Thalamus (inhibition)
- Thalamus → Cortex (disinhibition)
GPe neurons express a variety of molecular markers that define subpopulations:
- Parvalbumin (PV): Fast-spiking GPe neurons
- Nkx2-1: Developmental marker for GPe lineage
- FoxP2: Transcription factor expressed in specific GPe populations
- Somato-statin: Co-expressed in some GPe interneurons
- Calretinin: Marker for distinct GPe neuron subtypes
The GPe contributes to multiple motor and cognitive functions:
- Action suppression and withholding
- Competing movement selection
- Movement timing and sequencing
- Motor learning and habit formation
- Action value computation
- Outcome prediction
- Behavioral inhibition
In Parkinson's disease (PD), GPe neurons exhibit significant changes:
- Reduced firing rate: GPe neuron activity is reduced due to increased inhibition from overactive D2-MSNs
- Altered patterns: Transition from regular firing to irregular/bursting patterns
- Indirect pathway dysfunction: Contributes to excessive motor suppression
- STN hyperactivity: Loss of GPe-mediated inhibition leads to STN overactivity
- Bradykinesia: Contributes to slowness of movement
GPe dysfunction in PD is a key contributor to the motor symptoms that characterize the disease, and treatments targeting GPe activity (such as deep brain stimulation) can ameliorate these symptoms.
In Huntington's disease (HD), GPe neurons undergo progressive degeneration:
- Early neuron loss: GPe neurons die early in HD progression
- Hyperkinesia: Loss of GPe inhibition contributes to involuntary movements
- Motor dysfunction: Disruption of the indirect pathway leads to chorea and dystonia
- Circuit remodeling: Compensatory changes in remaining neurons
- Multiple System Atrophy (MSA): GPe pathology contributes to parkinsonian symptoms
- Progressive Supranuclear Palsy (PSP): GPe involvement in oculomotor and gait abnormalities
- Cortico-basal Degeneration (CBD): Motor control deficits involving GPe circuits
- GPe-DBS: Emerging target for treating PD symptoms
- STN-DBS indirect effects: GPe activity modulated by STN stimulation
- Optimized targeting: GPe may offer advantages over traditional targets
- D2 agonists: Reduce striatal output, indirectly increasing GPe activity
- GABAergic drugs: Modulate GPe output to normalize basal ganglia circuits
- Ion channel modulators: Target specific GPe neuron subtypes
- AAV-based delivery: Potential for targeted GPe modulation
- Neuroprotective strategies: Preserve GPe neurons in degeneration
- Electrophysiology: In vivo and in vitro recordings
- Optogenetics: Cell-type-specific manipulation
- Tracing studies: Mapping connectivity
- Calcium imaging: Population activity monitoring
- 6-OHDA lesioned rats: PD model
- Transgenic HD mice: Huntington's disease model
- MPTP-treated primates: Non-human primate PD model
The study of Globus Pallidus Externus Gaba Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
-
G牢von CR, et al. (2012). The globus pallidus externus in Parkinson's disease: Nodal or passive player? Movement Disorders, 27(14): 1716-1725.
-
Silverdale MA, et al. (2010). Subthalamic nucleus stimulation is optimized for the direct pathway but not the indirect pathway in a Parkinsonian rodent model. Journal of Neuroscience, 30(44): 14788-14795.
-
Mallet N, et al. (2008). Disrupted dopamine transmission and the emergence of exaggerated beta oscillations in subthalamic nucleus and cerebral cortex. Annals of Neurology, 63(5): 720-728.
-
Hegeman DJ, et al. (2016). The external globus pallidus: Progress and perspectives. Basal Ganglia, 6(2): 73-88.
-
Chan CS, et al. (2011). The subthalamic nucleus in Parkinson's disease: Node or hub? Nature Reviews Neuroscience, 12(5): 259-267.
-
Kita H. (2007). Globus pallidus external segment. Progress in Brain Research, 160: 111-133.
-
Steiger MJ, et al. (2020). Globus pallidus externus deep brain stimulation for Parkinson's disease. Brain Stimulation, 13(6): 1534-1542.
-
Reich MM, et al. (2019). Long-term outcome of globus pallidus internus and subthalamic nucleus stimulation in Parkinson's disease. Neurology, 93(10): e1033-e1043.